Home  /  News

News 

McAndrews Associate Invited to Present at International Institute for the Sociology of Law Workshop in Spain

Date: May 13, 2014 || McAndrews News

 

Yaping Zhang Receives McAndrews’ 2014 Diversity in Patent Law Fellowship

Date: May 9, 2014 || McAndrews News

 

Four McAndrews Attorneys Named “IP Stars” By Managing Intellectual Property Magazine

Date: May 9, 2014 || McAndrews News

 

Life Sciences Intellectual Property Review Names McAndrews Shareholder Nabeela Rasheed, Ph.D., To Editorial Board

Date: April 22, 2014 || McAndrews News

 

McAndrews Founding Partner John H. Held Named Volunteer of the Month by CARPLS

Date: April 17, 2014 || McAndrews News

 

McAndrews Shareholder Nabeela Rasheed, Ph.D., Honored as 2014 Distinguished Intellectual Property Alumna by Chicago-Kent Intellectual Property Law Society

Date: April 14, 2014 || McAndrews News

 

McAndrews Shareholder Christopher V. Carani to Present on Design Patent Law at the Kansas Bar Association’s 2014 Midwest Intellectual Property Institute

Date: April 14, 2014 || McAndrews News

 

District of New Jersey Allows ANDA Filer's Declaratory Judgment Action to Proceed Despite Covenant Not to Sue

Date: April 13, 2014 || IP Updates

Orange Book Blog
By Alex Menchaca

 

From Spoons to Smartphones: McAndrews Shareholder Christopher V. Carani to Present on Strategic Considerations for Product Design at The Industrial Designers Society of America Conference

Date: April 10, 2014 || McAndrews News

 

McAndrews Facilitated Divestiture of Stem Cell Business of Client Osiris Therapeutics for $100 Million

McAndrews guided client Osiris Therapeutics (NASDAQ:OSIR) in intellectual property matters involving
the sale of Osiris's culture-expanded mesenchymal stem cell (ceMSC) business (including Osiris' large
ceMSC patent estate) to Mesoblast International, SARL (ASX:MSB) (USOTC:MBLTY).

 

Page    11 12 13 14 15 16 17 18 19 20